Knockdown of FOXA1 enhances the osteogenic differentiation of human bone marrow mesenchymal stem cells partly via activation of the ERK1/2 signalling pathway

Lijun Li,Yibo Wang,Zhongxiang Wang,Deting Xue,Chengxin Dai,Xiang Gao,Jianfei Ma,Kai Hang,Zhijun Pan
DOI: https://doi.org/10.1186/s13287-022-03133-2
2022-09-06
Abstract:The available therapeutic options for large bone defects remain extremely limited, requiring new strategies to accelerate bone healing. Genetically modified bone mesenchymal stem cells (BMSCs) with enhanced osteogenic capacity are recognised as one of the most promising treatments for bone defects.
cell biology,medicine, research & experimental,cell & tissue engineering
What problem does this paper attempt to address?